Keyoung Hansoo Michael
SEC insider (Form 3/4/5 filer). CIK 0001824764. Director at Kairos Pharma, LTD. (KAPA). 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 8, 2025. Located in LOS ANGELES, CA.
Companies Keyoung Hansoo Michael has filed insider reports for
- Kairos Pharma, LTD. (KAPA): Director
Keyoung Hansoo Michael
CIK: 0001824764
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KAPA
Kairos Pharma, LTD.
Director